Masaki Daini

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 7 EPO patents, primarily in Heterocyclic Compounds. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Masaki Daini. Retrieved from https://idiyas.com/inventor/masaki-daini

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 81.0

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 7 (Patent Applications = 19)

Average Co-Inventor Count = 9.5

ph-index = 4

Forward Citations = 48(Granted Patents)

Location History:

Kanagawa, JP (2016 - 2022)
Fujisawa, JP (2020 - 2023)

Company Filing History:

21 out of 1,226

Takeda Pharmaceutical Company Limited

patents

Years Active: 2016-2026

Loading Chart...

Areas of Expertise:

Heterocyclic Compound

GPR139 Antagonists

Pyrrolidine Compound

Cyclopropanamine

Depression Treatment

Pharmaceutical Applications

Chemical Derivatives

Drug Development

NMDA Antagonist

Pyrazole

Imidazole

Bipyridine

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12723028 - Heterocyclic compound (2026-09-01),

2. 12637418 - Heterocyclic compounds as antagonist of NMDA (2026-05-26),

3. 12630534 - 1-((1H-pyrazol-4-yl)methyl)-3-(phenyl)-1,3-dihydro-2H-imidazol-2-one derivatives and related compounds as GPR139 antagonists for the treatment of e.g. depression (2026-05-19),

4. 12590086 - 3-((1H-pyrazol-4-yl)methyl)-6'-(phenyl)-2H-(1,2′-bipyridin)-2-one derivatives and related compounds as GPR139 antagonists for use in a method of treatment of e.g. depression (2026-03-31),

5. 12528802 - Heterocyclic compound (2026-01-20),

6. 11702419 - Heterocyclic compound and use thereof (2023-07-18),

7. 11459325 - Heterocyclic compound (2022-10-04),

8. 11319286 - Heterocyclic compound and application thereof (2022-05-03),

9. 11059780 - Substituted pyrrolidine compound and use thereof (2021-07-13),

10. 11034700 - Substituted pyrrolidine compound and use thereof (2021-06-15),

11. 10968213 - Cyclopropanamine compound and use thereof (2021-04-06),

12. 10807987 - Heterocyclic compound and use thereof (2020-10-20),

13. 10414761 - Cyclopropanamine compound and use thereof (2019-09-17),

14. 10406146 - Heterocyclic compound (2019-09-10),

15. 10357484 - Heterocyclic compound (2019-07-23),

Title: The Innovative Journey of Masaki Daini

Introduction: Masaki Daini, a pioneering inventor hailing from Kanagawa, Japan, has made significant contributions to the world of innovations with his groundbreaking ideas and inventions.

Latest Patents: Masaki Daini's latest patents showcase his continuous dedication to pushing the boundaries of technology and creativity, with a focus on improving everyday life through his inventions.

Career Highlights: Throughout his illustrious career, Masaki Daini has been recognized for his inventive spirit and problem-solving skills. His inventions have not only garnered critical acclaim but have also made a tangible impact on various industries.

Collaborations: Masaki Daini has collaborated with leading research institutions, universities, and innovative companies to further develop and refine his inventions. These collaborations have been instrumental in bringing his ideas to life and making them accessible to the public.

Conclusion: Masaki Daini's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of inventions. His work continues to inspire future generations of inventors to think outside the box and create solutions that shape the world we live in.

Profile summary based on public USPTO records.